A practical guide to the treatment of neurogenic orthostatic hypotension

Canadian Journal of Neurological Sciences

Volumn 41, Issue 2, 2014, Pages 156-163

  Berger, Michael J ^a   Kimpinski, Kurt ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOMIDODRINE; FLUDROCORTISONE; MIDODRINE; PYRIDOSTIGMINE; STRONTIUM; UNCLASSIFIED DRUG; ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; MINERALOCORTICOID;

AEROBIC EXERCISE; ANXIETY; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE MONITORING; BLURRED VISION; CLINICAL FEATURE; COGNITIVE DEFECT; COMPRESSION STOCKING; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DIZZINESS; EXTRACELLULAR SPACE; FAINTNESS; FATIGUE; FLUID INTAKE; HEART PALPITATION; HEART STROKE VOLUME; HEART VOLUME; MUSCLE ISOMETRIC CONTRACTION; NAUSEA; NECK PAIN; NEUROGENIC ORTHOSTATIC HYPOTENSION; ORTHOSTATIC HYPOTENSION; PALLOR; PARKINSON DISEASE; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PLASMA VOLUME; PREDICTIVE VALUE; PRESYNCOPE; PRIORITY JOURNAL; PURE AUTONOMIC FAILURE; REVIEW; SALT INTAKE; SALT LOADING; SENSITIVITY AND SPECIFICITY; TINNITUS; VALSALVA MANEUVER; WEAKNESS; AUTONOMIC NERVOUS SYSTEM DISEASES; CENTRAL NERVOUS SYSTEM TUMOR; COMPLICATION; DISEASE MANAGEMENT; FEEDING BEHAVIOR; HUMAN; HYPOTENSION, ORTHOSTATIC; KINESIOTHERAPY; MULTIPLE SCLEROSIS; TILT TABLE TEST;

AUTONOMIC NERVOUS SYSTEM DISEASES; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHOLINESTERASE INHIBITORS; DISEASE MANAGEMENT; EXERCISE THERAPY; FLUDROCORTISONE; FOOD HABITS; HUMANS; HYPOTENSION, ORTHOSTATIC; MIDODRINE; MINERALOCORTICOIDS; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; PYRIDOSTIGMINE BROMIDE; STOCKINGS, COMPRESSION; SYMPATHOMIMETICS; TILT-TABLE TEST;

EID: 84894442360     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100016528     Document Type: Review

References (56)

1. Rose KM, Eigenbrodt ML, Biga RL, et al. Orthostatic hypotension predicts mortality in middle-aged adults: the atherosclerosis risk in Communities (ariC) Study. Circulation. 2006;114(7): 630-6.
2. Cordeiro RC, Jardim JR, Perracini MR, Ramos lr. Factors associated with functional balance and mobility among elderly diabetic outpatients. Arq Bras endocrinol Metabol. 2009;53(7): 834-43.
3. Bendini C, Angelini A, Salsi F, et al. Relation of neurocardiovascular instability to cognitive, Emotional and functional domains. Arch gerontol geriatr. 2007;44 Suppl 1:69-74.
4. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, Neurally mediated syncope and the postural tachycardia syndrome. Clin auton res. 2011;21(2):69-72.
5. Low PA, Singer W. Management of neurogenic orthostatic hypotension: an update. Lancet neurol. 2008;7(5):451-8.
6. Low PA, Fealy rd. Managment of neurogenic orthostatic hypotension. In: low PA, Benarroch EE, Editors. Clinical autonomic disorders. 3rd ed. Philadelphia: Wolters Kluwer health/lippincott Williams & Wilkins; 2008. P. 547-59.
7. Freeman R. Clinical practice: neurogenic orthostatic hypotension. N eng J Med. 2008;358:615-24.
8. Metzler M, Duerr S, Granata R, Krismer F, Robertson D, Wenning gK. Neurogenic orthostatic hypotension: pathophysiology, Evaluation, and management. J neurol. 2013;260(9):2212-19.
9. Smit AA, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J physiol. 1999;519 pt 1:1-10.
10. Masaki KH, Schatz IJ, Burchfiel CM, et al. Orthostatic hypotension predicts mortality in elderly men: the honolulu heart program. Circulation. 1998;98(21):2290-5.
11. Ooi WL, Barrett S, Hossain M, Kelley-gagnon M, Lipsitz la. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, Elderly population. JaMa. 1997;277(16): 1299-304.
12. Lanier JB, Mote MB, Clay eC. Evaluation and management of orthostatic hypotension. Am fam physician. 2011;84(5):527-36.
13. Poon IO, Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin pharm ther. 2005;30(2):173-8.
14. Mathias CJ, Mallipeddi R, Bleasdale-Barr K. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. J neurol. 1999;246(10):893-8.
15. Low PA, Opfer-gehrking TL, Mcphee BR, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin proc. 1995;70(7):617-22.
16. Freeman R. Current pharmacologic treatment for orthostatic hypotension. Clin auton res. 2008;18 Suppl 1:14-18.
17. Freeman R. Treatment of orthostatic hypotension. Semin neurol. 2003;23(4):435-42.
18. Fujimura J, Camilleri M, Low PA, Novak V, Novak P, Opfergehrking tl. Effect of perturbations and a meal on superior mesenteric artery flow in patients with orthostatic hypotension. J auton nerv Syst. 1997;67(1-2):15-23.
19. Gupta V, Lipsitz la. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med. 2007;120(10):841-7.
20. Cooke J, Carew S, O'Connor M, Costelloe A, Sheehy T, Lyons D. Sitting and standing blood pressure measurements are not accurate for the diagnosis of orthostatic hypotension. QJM. 2009;102(5):335-9.
21. Wieling W, Krediet CT, Van dijk N, Linzer M, Tschakovsky Me. Initial orthostatic hypotension: review of a forgotten condition. Clin Sci (lond). 2007;112(3):157-65.
22. Gibbons CH, Freeman R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology. 2006;67(1): 28-32.
23. Fedorowski A, Melander O. Syndromes of orthostatic intolerance: a hidden danger. J intern Med. 2012;273(4):322-35.
24. Logan IC, Witham Md. Efficacy of treatments for orthostatic hypotension: a systematic review. Age ageing. 2012;41(5): 587-94.
25. Omboni S, Smit AA, Van lieshout JJ, Settels JJ, Langewouters GJ, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin Sci (lond). 2001;101(6):609-18.
26. Wieling W, Colman N, Krediet CT, Freeman R. Nonpharmacological treatment of reflex syncope. Clin auton res. 2004;14 Suppl 1:62-70.
27. Bouvette CM, Mcphee BR, Opfer-gehrking TL, Low pa. Role of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentation. Mayo Clin proc. 1996;71(9):847-53.
28. Ten harkel AD, Van lieshout JJ, Wieling W. Effects of leg muscle pumping and tensing on orthostatic arterial pressure: a study in normal subjects and patients with autonomic failure. Clin Sci (lond). 1994;87(5):553-8.
29. Wieling W, Van lieshout JJ, Van leeuwen aM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin auton res. 1993;3(1):57-65.
30. Wieling W, Van lieshout JJ, Hainsworth R. Extracellular fluid volume expansion in patients with posturally related syncope. Clin auton res. 2002;12(4):242-9.
31. El-Sayed H, Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart. 1996;75(2):134-40.
32. Mtinangi BL, Hainsworth R. Early effects of oral salt on plasma volume, Orthostatic tolerance, and baroreceptor sensitivity in patients with syncope. Clin auton res. 1998;8(4):231-5.
33. Naschitz JE, Slobodin G, Elias N, Rosner I. The patient with supine hypertension and orthostatic hypotension: a clinical dilemma. Postgrad Med J. 2006;82(966):246-53.
34. World health organization. Global status report on noncommunicable diseases. 2010:16-21.
35. Jordan J. Acute effect of water on blood pressure. What do we know? Clin auton res. 2002;12(4):250-5.
36. Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D. A potent pressor response elicited by drinking water. Lancet. 1999; 353(9154):723.
37. Jordan J, Shannon JR, Diedrich A, Black B, Robertson D, Biaggioni I. Water potentiates the pressor effect of ephedra alkaloids. Circulation. 2004;109(15):1823-5.
38. Henry R, Rowe J, O'Mahony D. Haemodynamic analysis of efficacy of compression hosiery in elderly fallers with orthostatic hypotension. Lancet. 1999;354(9172):45-6.
39. Smit AA, Wieling W, Fujimura J, et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin auton res. 2004;14(3):167-75.
40. Denq JC, Opfer-gehrking TL, Giuliani M, Felten J, Convertino VA, Low pa. Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin auton res. 1997;7(6):321-6.
41. Mtinangi BL, Hainsworth R. Effects of moderate exercise training on plasma volume, Baroreceptor sensitivity and orthostatic tolerance in healthy subjects. Exp physiol. 1999;84(1):121-30.
42. Mtinangi BL, Hainsworth R. Increased orthostatic tolerance following moderate exercise training in patients with unexplained syncope. Heart. 1998;80(6):596-60.
43. Low DA, Da nobrega AC, Mathias CJ. Exercise-induced hypotension in autonomic disorders. Auton neurosci. 2012;171 (1-2):66-78.
44. Wright RA, Kaufmann HC, Perera R, et al. A double-blind, Doseresponse study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51(1):120-4.
45. Low pa GJ, Freeman R, Sheng KN, Mcelligott Ma. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, Double-blind multicenter study. Midodrine Study group. JAMA. 1997;278(5):388.
46. Singer W, Opfer-gehrking TL, Nickander KK, Hines SM, Low pa. Acetylcholinesterase inhibition in patients with orthostatic intolerance. J Clin neurophysiol. 2006;23(5):476-81.
47. Singer W, Sandroni P, Opfer-gehrking TL, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch neurol. 2006;63(4):513-18.
48. Gales BJ, Gales Ma. Pyridostigmine in the treatment of orthostatic intolerance. Ann pharmacother. 2007;41(2):314-18.
49. Van lieshout JJ, Ten harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin auton res. 2000;10(1): 35-42.
50. Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N engl J Med. 1979;301(2):68-73.
51. Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr Md. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology. 1992;42(3 pt 1):590-3.
52. Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin auton res. 2003;13(2):106-8.
53. Sasaki E, Kitaoka H, Ohsawa N. Postprandial hypotension in patients with non-insulin-dependent diabetes mellitus. Diabetes res Clin pract. 1992;18(2):113-21.
54. Armstrong E, Mathias CJ. The effects of the somatostatin analogue, Octreotide, On postural hypotension, Before and after food ingestion, In primary autonomic failure. Clin auton res. 1991;1 (2):135-40.
55. Hoeldtke RD, Streeten dh. Treatment of orthostatic hypotension with erythropoietin. N engl J Med. 1993;329(9):611-15.
56. Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin auton res. 1995;5(4):211-13.